Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

Demand for weight-loss drugs surged throughout 2024, outpacing supply for most of the year. In December, Novo Holdings, an ...

It’s a problem that has plagued European governments for decades, from the credit-crunch bank bailouts of 2008 to more recent ...

Terence Flynn, Morgan Stanley, inquired about Zepbound payer dynamics and access. Patrik Jonsson explained that Medicare coverage related to obstructive sleep apnea (OSA) is anticipated in the second ...

The popularity of the new class of weight-loss drugs, known as GLP-1s, has made Eli Lilly the biggest pharmaceutical company and its Danish rival, Novo Nordisk, Europe’s most valuable company.

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

Eli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter ...

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit these popular categories the hardest.

Eli Lilly's stock rose 3.3% on Feb. 6 after a ... Elon Musk Is Killing Tesla’s Europe Business. Should You Sell TSLA Stock or Buy the Dip? CrowdStrike Shook Investor Confidence With Its 2024 ...

But over time, your decision to buy or sell a company’s stock should be based on what you believe will happen in the future.